Evidence map›Paper›PMID 28993407›Full record

ArticleCirculation. Cardiovascular genetics2017

Heterozygous Null

Kamaldeep Panach, Abhimanyu Garg, Zahid Ahmad

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Cardiovascular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kamaldeep PanachFrom the Division of Endocrinology (K.P.), Department of Internal Medicine (K.P.), and Department of Internal Medicine, Division of Nutrition and Metabolic Diseases, Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX (A.G., Z.A.). kpanach@gmail.com.
Abhimanyu GargFrom the Division of Endocrinology (K.P.), Department of Internal Medicine (K.P.), and Department of Internal Medicine, Division of Nutrition and Metabolic Diseases, Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX (A.G., Z.A.).
Zahid AhmadFrom the Division of Endocrinology (K.P.), Department of Internal Medicine (K.P.), and Department of Internal Medicine, Division of Nutrition and Metabolic Diseases, Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX (A.G., Z.A.).

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
Molecular Basis of Autosomal Dominant Hypercholesterolemia in a Multiethnic CohorK23HL114884 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI AHMAD, ZAHID · 2013 to 2017
$839k
NCATS NIH HHS UL1 TR001105NHLBI NIH HHS K23 HL114884
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Achilles TendonAgedAlcoholismHeterozygoteHumansHyperlipoproteinemia Type IILipidsMaleMutationPhenotypePolymorphism, Single NucleotideReceptors, LDLXanthomatosisLDLR protein, humanLipidsReceptors, LDL

Identifiers

PMID28993407
PMCPMC5657548

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.